INSM•prnewswire•
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Summary
BRIDGEWATER, N.J., Dec. 4, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced the granting of inducement...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 4, 2025 by prnewswire